Indaptus Therapeutics, Inc. (INDP) Tops Q1 EPS by 8c

Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q1 EPS of ($0.51), $0.08 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Morgan Stanley Starts Target Hospitality (TH) at Overweight
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15